Wuxi apptec won the "2018 Enterprise Award" of Baihua Association

November 15, 2018 / AP / -- yesterday, at the Fifth China Medical and health summit, Wuxi apptec won the "company of the year" of the 2018 China Medical award issued by the Bay helix group, which aims to recognize the enterprises that have made outstanding achievements in China's medical industry and made outstanding contributions to the great health ecosystem Dr Yang Qing, executive vice president and chief commercial officer of Wuxi apptec, was invited to attend and receive the award Baihua Association fully affirmed the efforts made by Wuxi apptec to build the highest, broadest and deepest capability and technology platform of global pharmaceutical and health industry Wuxi apptec's enabling platform is carrying thousands of R & D and innovation projects of more than 3000 innovation partners around the world, and is committed to bringing more new drugs and good drugs to patients around the world "Thank you Baihua Association for your support and recognition." Dr Yang Qing, executive vice president and chief business officer of Wuxi Pharmaceutical Co., Ltd., said, "by constantly improving our enabling platform and creating a large health ecosystem, Wuxi Pharmaceutical Co., Ltd helps innovative entrepreneurs realize the dream of new drug research and development, enables doctors to treat patients better, enables patients to get better treatment, and hopes to realize the dream of" no hard drugs, no hard diseases in the world "as soon as possible." Baihua association is composed of outstanding Chinese in the field of global life technology and medical health industry This year's China Medical award includes five awards, including "annual R & D Achievement Award", "annual Cooperation Award", "annual business achievement award", "annual enterprise award" and "annual outstanding individual award" About Wuxi apptec (Stock Code: 603259) is a leading international open-ended capability and technology platform company, which provides a full range of integrated laboratory R & D and production services from drug discovery, development to marketization in the fields of global pharmaceutical and medical devices With the purpose of taking research as the first task and customer as the center, Wuxi apptec helps global customers shorten the R & D cycle of drugs and medical devices and reduce the R & D cost through a cost-effective and efficient service platform The platform of Wuxi apptec includes the R & D and production of chemical drugs, the R & D and production of cell and gene therapy, the R & D of drugs, and the testing of medical devices It is carrying thousands of R & D and innovation projects from more than 3000 innovation partners in more than 30 countries around the world It is committed to bringing the latest and best medicine and health products to patients around the world, and realizing that "there is no hard medicine in the world, hard to treat Sick dream Source: yaomingkant